Abstract
AbstractDrug disposition in humans is influenced by its absorption, volume of distribution, metabolism, and elimination. Drug metabolism involves Phase I and II biotransformations, most of which occur in the human liver. This chapter focuses on how physiological states may affect hepatic metabolism and the impact of liver disease on drug handling. The liver is vulnerable to a wide variety of insults, but the repertoire of its response to injury is limited. Likewise, the functional consequences of liver disease on drug disposition are determined by the extent of the injury, as opposed to its etiology. Predicting drug metabolism in patients with liver disease is particularly challenging. No universal rule can be applied to the modification of drug dosages in patients with liver disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
